← Eichor
Study identifier: NCT06928727 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Ocular Characteristics in Patients With Craniosynostosis

Condition: Craniosynostosis · Strabismus · Intracranial Hypertension  ·  Sponsor: Centre Hospitalier Universitaire, Amiens

PhaseN/A
Planned participants65
Who can joinAll sexes, N/A to no upper limit
Healthy volunteersNo

About this study

Craniosynostosis are cranial deformations due to the premature closure of one or more cranial sutures. These deformations affect approximately one in 2.500 births. In most cases, craniosynostoses are isolated with unknown (non syndrome). On the other hand, 20% of these deformations are associated with other concentration (syndrome). Craniosynostosis has morphological (associated dysmorphism) and functional (growth conflict between the skull and the brain) repercussions. Ophthalmological disorders are frequent: refractive disorders, oculomotor disorders, optic nerve damage, sensory damage. This retrospective study aims to describe the ocular clinical characteristics associated with craniosynostosis in patients followed at the Amiens University Hospital.

This description comes directly from the study's public registry record.

Talk to the study team

Tran Thi Ha Chau, Pr  ·  33+322089224  ·  tran.chau@chu-amiens.fr

Always discuss trial participation with your own doctor first.

Locations (1)

CHRU AmiensAmiens, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06928727